INDEPENDENT THINKING. BETTER EVIDENCE.WEIGHT, HEALTH & THE SCIENCE BETWEEN
News

FDA requires GLP-1 eye warning: what NAION data show

The new class-wide action rests on rare trial events and real-world comparisons that need careful interpretation.

Editorial evidence review ·
Two adults seated facing each other while one holds a small penlight near the other’s eye.
Conceptual editorial illustration for MyWeightLab. It does not depict a medicinal product, measured trial result or treatment recommendation.

Evidence and fact-checking standards · Report a correction

Cookie policy